About: Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 06 April 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu n'abril de 2020 (ast) наукова стаття, опублікована 6 квітня 2020 (uk) scientific article published on 06 April 2020 (en)
publication date	wds:Q95611267-F4B6914A-F994-41BA-A9CE-A518DCD6FDC0
publication date	2020-04-06 00:00:00Z (xsd:dateTime)
author name string	wds:Q95611267-03ECB4E0-B62D-4EE6-A320-2211AC064624 wds:Q95611267-24473CA8-BD4F-466A-ACC8-5DF726424FEB wds:Q95611267-26F50A67-3FE5-4F50-9E30-02D0431B0562 wds:Q95611267-2C188E15-D7D4-4A8B-869D-1FF5C3463AAB wds:Q95611267-3095DA22-8172-4FF2-AAC6-447BFC39E701 wds:Q95611267-3450FBA0-92FD-4EF3-9F49-CF6A5B280871 wds:Q95611267-3EE8475A-2401-4963-860A-D6797B04E427 wds:Q95611267-3F41F3EF-CFDC-45B8-9381-8FA702AB2218 wds:Q95611267-42B92BAC-F5FA-4DD5-9DF8-2B0382AB0A47 wds:Q95611267-6B6AF1E6-6CE5-493A-98F8-2BC26C8B3F19 wds:Q95611267-8CE42EC8-D9D0-48F4-938A-0672D3C59E7A wds:Q95611267-BC0A7B0B-8A8A-4B3C-8A0D-6B80B9E76A9E wds:Q95611267-D02E142D-3A91-47C5-8A17-6145BBC0AAA4 wds:Q95611267-F7226B5F-9DA3-4FB7-8D41-5CE3ADBBFFED
author name string	Jun Chen Mei Liu Hongzhou Lu Yun Ling Jinghe Huang Lu Lu Shibo Jiang Fan Wu Yuling Zhang Yumei Wen Jingna Xun Shuai Xia Qimin Wang Aojie Wang
rdfs:label	Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (en) Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (nl)
skos:prefLabel	Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (en) Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (nl)
name	Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (en) Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (nl)
title	wds:Q95611267-C2758DAC-036B-40E9-84F2-D88604C85596
title	Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (en)
instance of	wds:Q95611267-B551ADD4-E09D-42BC-A60F-C67BE5588006
instance of	scholarly article
main subject	wds:Q95611267-0BC16752-4F71-4F0B-94C3-A84D27E2C11F wds:Q95611267-E7ED1F55-F29C-4725-BDDE-00E955600B83
main subject	SARS-CoV-2 COVID-19 mortality
DOI	wds:Q95611267-196475A8-A57D-49A7-9C64-FEEE716A6D02
DOI	http://dx.doi.org/10.1101/2020.03.30.20047365
DOI	10.1101/2020.03.30.20047365
Semantic Scholar corpus ID	wds:Q95611267-1BB77CE8-7503-4E43-AAFA-40F3959B8B6C
Semantic Scholar corpus ID	215782229
Dimensions Publication ID	wds:Q95611267-B8C53AD2-AF6D-4B86-93F2-2AA9AEE7CCD8
Dimensions Publication ID	1126173131
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q95611267
is cites work of	What the immune response to the coronavirus says about the prospects for a vaccine Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses Distinct conformational states of SARS-CoV-2 spike protein Cell entry mechanisms of SARS-CoV-2 Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection Neutralizing antibody response in mild COVID-19 The potential danger of suboptimal antibody responses in COVID-19 Will antibody tests for the coronavirus really change everything? SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses Predicting the second wave of COVID-19 in Washtenaw County, MI Severe SARS-CoV-2 patients develop a higher specific T-cell response Universal coronavirus vaccines: the time to start is now Dissecting antibody-mediated protection against SARS-CoV-2 Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2 Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review
is cites work of	wds:Q98564950-0BF3BD07-E458-4C8D-BF3A-1D3A6801F7A2 wds:Q94589965-bb37b673-4698-23e2-278c-2b938fe7cb21 wds:Q99350314-D5A16CE3-4545-48AD-8538-A4204054CC2F wds:Q96642703-4981923B-C177-43DA-A329-9EAD123D0A5A wds:Q97531181-502BE330-2208-4CA8-B067-B00D49EC24B0 wds:Q104616252-F3D79E25-EF3D-4E08-8BD2-E6D6F4ADB056 wds:Q96304264-B56BF480-6651-4C20-854C-0E2C2157F158 wds:Q94452366-E11114C0-23AA-4C8F-8786-7005C3563E7F wds:Q97533646-118CFB88-A74D-498B-894D-AC794A508BC5 wds:Q98891366-3A64F00D-D992-4592-B1E0-35841C6BE459 wds:Q100524175-C68F1EE4-1A1D-4CB7-AE4F-E513501AF46B wds:Q98513801-D8485EA3-FF51-4734-B161-026C518CE7F4 wds:Q107076654-3C808435-7D33-41F7-A5DD-82A14721747F wds:Q92130769-00DC74CC-A512-4A52-A27F-09D6B71F2759 wds:Q96230541-16AA8FDF-0B95-43F2-858A-F99AC8F5B891 wds:Q98906660-62626673-97F0-408A-9BB8-A09251B645E0 wds:Q97639235-07F9692E-63B0-4831-A30F-45A435CCD939 wds:Q97642571-8E5C1821-CCC1-4D93-860F-B2DDBFE9AC04

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software